Decline
发表于 2025-3-25 07:07:34
Wolfgang Budde,Frank Früchtel,Wolfgang Hintenology intervention, and changes in clinician reimbursement. Attention to all of these domains will be required for comparative effectiveness research findings to be disseminated to clinicians in a way that will improve patient care and health outcomes.
低三下四之人
发表于 2025-3-25 08:02:51
http://reply.papertrans.cn/24/2309/230875/230875_22.png
Brain-Imaging
发表于 2025-3-25 12:10:30
http://reply.papertrans.cn/24/2309/230875/230875_23.png
cancer
发表于 2025-3-25 17:07:35
http://reply.papertrans.cn/24/2309/230875/230875_24.png
人造
发表于 2025-3-26 00:04:16
http://reply.papertrans.cn/24/2309/230875/230875_25.png
热心助人
发表于 2025-3-26 01:50:10
http://reply.papertrans.cn/24/2309/230875/230875_26.png
debouch
发表于 2025-3-26 07:22:03
http://reply.papertrans.cn/24/2309/230875/230875_27.png
perpetual
发表于 2025-3-26 08:56:01
Patient-Centred Comparative Effectiveness Research,ment’s failure through reliance on randomized controlled trials measuring efficacy and not the real-world effectiveness of treatment options. Several recent initiatives energizing the need for comparative effectiveness research have also aligned with the recognized need for patient participation in all aspects of healthcare research and practice.
liposuction
发表于 2025-3-26 16:13:06
Promotion Innovation and Health: Personalized Medicine or Comparative Effectiveness Research,ms of between $38 and $74 billion and would reduce the number of 57 new products over the decade. We conservatively estimate that the foregone social value of biomarker-based innovation would be $10 trillion over 10 years.
使更活跃
发表于 2025-3-26 19:01:01
Sources of Data for Comparative Effectiveness Research,lity, certification and standardization, interoperability, linking and integrating data sources, and ethics, legality, and privacy are discussed. The chapter ends with an example of how these same data can be transformed from research back into clinical practice to improve care and, thus, to further the ..